chr2:136114349:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr2:136,871,919-136,876,747 |
hg38 | chr2:136,114,349-136,119,177 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.027 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
<0.001 | cerebral infarction | NA | BeFree | Detail | |
0.002 | Malignant tumor of cervix | ATO inhibited CXCR4-mediated cervical cancer cell invasion in vitro and distant ... | BeFree | 25047463 | Detail |
0.002 | Malignant tumor of cervix | Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. | BeFree | 25114911 | Detail |
<0.001 | chondrosarcoma | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | Colonic Polyps | NA | BeFree | Detail | |
0.008 | colorectal carcinoma | The association of CXCR4 expression with prognosis and clinicopathological indic... | BeFree | 24422942 | Detail |
0.008 | colorectal carcinoma | SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colore... | BeFree | 25150783 | Detail |
0.008 | colorectal carcinoma | Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knock... | BeFree | 25866254 | Detail |
0.011 | Colorectal Neoplasms | NA | BeFree,LHGDN | Detail | |
0.002 | Coronary heart disease | NA | GAD | Detail | |
<0.001 | craniopharyngioma | High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomato... | BeFree | 24934367 | Detail |
0.004 | adenoid cystic carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Phyllodes Tumor | NA | BeFree | Detail | |
<0.001 | Presenile dementia | NA | BeFree | Detail | |
<0.001 | Diabetes | These observations demonstrate a potentially reno-protective role for CXCR4 in d... | BeFree | 25549045 | Detail |
<0.001 | diabetes mellitus | These observations demonstrate a potentially reno-protective role for CXCR4 in d... | BeFree | 25549045 | Detail |
0.005 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
<0.001 | Diabetic Nephropathy | Although CXCR4 expression was also increased in biopsy tissue from patients with... | BeFree | 25549045 | Detail |
<0.001 | Drug abuse | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
<0.001 | Esophageal Neoplasms | Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for t... | BeFree | 26130416 | Detail |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
<0.001 | Gastrointestinal Neoplasms | NA | BeFree | Detail | |
<0.001 | Gingival Diseases | NA | BeFree | Detail | |
0.007 | glioblastoma | VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a ... | BeFree,LHGDN | 25676691 | Detail |
0.017 | Glioma | NA | BeFree,LHGDN | Detail | |
<0.001 | Graves Disease | NA | BeFree | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
<0.001 | hemolytic-uremic syndrome | NA | BeFree | Detail | |
<0.001 | Hepatitis, Alcoholic | NA | BeFree | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Von Hippel-Lindau syndrome | NA | BeFree | Detail | |
0.095 | HIV Infections | Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in pa... | BeFree,GAD,LHGDN | 24205895 | Detail |
0.095 | HIV Infections | The CX3CR1 A allele and lower genetic scores may restrict the switch of HIV-1 tr... | BeFree,GAD,LHGDN | 24750723 | Detail |
0.095 | HIV Infections | CXCR4 usage can emerge independently, in multiple lineages, along the course of ... | BeFree,GAD,LHGDN | 25032817 | Detail |
0.095 | HIV Infections | When pDC were depleted prior to HIV-1 infection, the induction of IFN-I and inte... | BeFree,GAD,LHGDN | 25077616 | Detail |
0.095 | HIV Infections | Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as ent... | BeFree,GAD,LHGDN | 25330146 | Detail |
0.095 | HIV Infections | Our study demonstrates that individuals may be infected by minority X4 viruses f... | BeFree,GAD,LHGDN | 25730507 | Detail |
0.095 | HIV Infections | The interaction of HIV-1 and target cells involves sequential binding of the vir... | BeFree,GAD,LHGDN | 25966986 | Detail |
0.095 | HIV Infections | Chemokine receptors CXCR4 and CCR5 are indispensable co-receptors for HIV-1 entr... | BeFree,GAD,LHGDN | 26018859 | Detail |
0.095 | HIV Infections | HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors ... | BeFree,GAD,LHGDN | 26178998 | Detail |
0.095 | HIV Infections | Treatment failure with drug-resistant virus is particularly interesting because ... | BeFree,GAD,LHGDN | 26339063 | Detail |
0.003 | Hyperplasia | NA | LHGDN | Detail | |
0.003 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
<0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
0.002 | ischemia | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.003 | Kidney Neoplasm | NA | LHGDN | Detail | |
0.010 | leukemia | There is marked evidence that the SDF-1/CXCR4 axis is involved in the pathogenes... | BeFree,LHGDN | 25070183 | Detail |
0.010 | leukemia | CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphobl... | BeFree,LHGDN | 26058076 | Detail |
0.010 | chronic lymphocytic leukemia | It has previously been shown that SDF1/CXCR4-induced migration is dependent on a... | BeFree,GAD,LHGDN | 25294819 | Detail |
0.010 | chronic lymphocytic leukemia | Circulating chronic lymphocytic leukemia (CLL) cells display an abnormal increas... | BeFree,GAD,LHGDN | 26282174 | Detail |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
<0.001 | lymphoid leukemia | NA | BeFree | Detail | |
0.002 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.009 | Leukemia, Myelocytic, Acute | CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid le... | BeFree,LHGDN | 24500843 | Detail |
0.009 | Leukemia, Myelocytic, Acute | The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression. | BeFree,LHGDN | 25193961 | Detail |
0.009 | Leukemia, Myelocytic, Acute | Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. | BeFree,LHGDN | 25294819 | Detail |
0.009 | Leukemia, Myelocytic, Acute | A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activ... | BeFree,LHGDN | 25312253 | Detail |
0.009 | Leukemia, Myelocytic, Acute | Patients with defective NK cells showed a profound gene expression decrease in A... | BeFree,LHGDN | 26246143 | Detail |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.002 | Myeloid Leukemia, Chronic | Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemi... | BeFree | 25265345 | Detail |
<0.001 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
0.001 | leukopenia | NA | BeFree | Detail | |
<0.001 | Liver diseases | NA | BeFree | Detail | |
0.003 | Liver neoplasms | NA | BeFree,GAD | Detail | |
0.003 | Lung diseases | NA | LHGDN | Detail | |
0.022 | Lung Neoplasms | Immunophenotypic analysis of lung tumor cells intravenously injected or spontane... | BeFree,LHGDN | 26141860 | Detail |
0.004 | Lupus Erythematosus, Systemic | NA | BeFree,LHGDN | Detail | |
0.003 | Lymphatic Metastasis | NA | BeFree,GAD | Detail | |
0.002 | lymphoma | NA | BeFree | Detail | |
0.003 | Lymphoma, Follicular | NA | BeFree,LHGDN | Detail | |
0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
<0.001 | lymphopenia | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of stomach | Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine re... | BeFree | 24929539 | Detail |
0.004 | medulloblastoma | These results demonstrate crosstalk among WIP1, CXCR4 and GRK5, which may be imp... | BeFree,LHGDN | 24632620 | Detail |
0.004 | medulloblastoma | Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma. | BeFree,LHGDN | 25400097 | Detail |
0.024 | melanoma | Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with ... | BeFree,LHGDN | 25211166 | Detail |
0.024 | melanoma | Deregulation of the CXCR4/CXCL12 axis was reported in melanoma tumorigenesis whi... | BeFree,LHGDN | 25839711 | Detail |
0.024 | melanoma | PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma. | BeFree,LHGDN | 26205821 | Detail |
<0.001 | multiple endocrine neoplasia type 2B | NA | BeFree | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
0.002 | Mouth Neoplasms | NA | GAD | Detail | |
0.006 | multiple myeloma | In 176 paired clinical samples, BTK and CXCR4 expression was lower in myeloma ce... | BeFree | 25083818 | Detail |
0.006 | multiple myeloma | It has previously been shown that SDF1/CXCR4-induced migration is dependent on a... | BeFree | 25294819 | Detail |
0.006 | multiple myeloma | Several chemokines/chemokine receptors such as CXCL12, CCL3, CXCR4 and CCR1 attr... | BeFree | 25962684 | Detail |
0.005 | multiple sclerosis | NA | BeFree,GAD | Detail | |
<0.001 | Mycobacterium avium-intracellulare Infection | NA | BeFree | Detail | |
<0.001 | myelofibrosis | This trafficking pattern could not be attributed to discordant expression of int... | BeFree | 25461253 | Detail |
0.003 | myositis | NA | LHGDN | Detail | |
0.246 | Neoplasm Metastasis | In addition, a significant association was revealed between positive CXCR4 expre... | BeFree,CTD_human,LHGDN | 24422942 | Detail |
0.246 | Neoplasm Metastasis | Because breast cancer patient survival inversely correlates with metastasis, we ... | BeFree,CTD_human,LHGDN | 24467226 | Detail |
0.246 | Neoplasm Metastasis | Furthermore, coexpression of HIF-1α and CXCR4 was significantly higher in patien... | BeFree,CTD_human,LHGDN | 24618817 | Detail |
0.246 | Neoplasm Metastasis | This study reveals the highly plastic and dynamic nature of CXCR4 expression in ... | BeFree,CTD_human,LHGDN | 24651452 | Detail |
0.246 | Neoplasm Metastasis | Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by dere... | BeFree,CTD_human,LHGDN | 24840182 | Detail |
0.246 | Neoplasm Metastasis | Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine re... | BeFree,CTD_human,LHGDN | 24929539 | Detail |
0.246 | Neoplasm Metastasis | The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell... | BeFree,CTD_human,LHGDN | 24992171 | Detail |
0.246 | Neoplasm Metastasis | More promisingly, miR-302a inhibited the invasion and metastasis of breast cance... | BeFree,CTD_human,LHGDN | 25030358 | Detail |
0.246 | Neoplasm Metastasis | Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A... | BeFree,CTD_human,LHGDN | 25047463 | Detail |
0.246 | Neoplasm Metastasis | These findings demonstrate the first evidence that epigenetic silencing of CXCR4... | BeFree,CTD_human,LHGDN | 25114911 | Detail |
0.246 | Neoplasm Metastasis | CXCR7 was not detectable in secondary tumors but CXCR4 was expressed. | BeFree,CTD_human,LHGDN | 25227814 | Detail |
0.246 | Neoplasm Metastasis | CXCR4 is a marker of poor prognosis in various neoplasms, correlating with metas... | BeFree,CTD_human,LHGDN | 25231113 | Detail |
0.246 | Neoplasm Metastasis | The subsequent increase in circulating granulocyte number, with an increase in s... | BeFree,CTD_human,LHGDN | 25270220 | Detail |
0.246 | Neoplasm Metastasis | The chemokine receptor CXCR4 and signal transducer and activator of transcriptio... | BeFree,CTD_human,LHGDN | 25310198 | Detail |
0.246 | Neoplasm Metastasis | Our findings suggest that ΔNP63α regulation of CXCR4 may have strong implication... | BeFree,CTD_human,LHGDN | 25376609 | Detail |
0.246 | Neoplasm Metastasis | SNCG, MAP2, SDF-1 and CXCR4 may play an important role in the carcinogenesis, pr... | BeFree,CTD_human,LHGDN | 25400739 | Detail |
0.246 | Neoplasm Metastasis | The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarco... | BeFree,CTD_human,LHGDN | 25444927 | Detail |
0.246 | Neoplasm Metastasis | In conclusion, our result shows that high CXCR4 expression is associated with IH... | BeFree,CTD_human,LHGDN | 25471741 | Detail |
0.246 | Neoplasm Metastasis | The present study indicates that the inflammatory cytokine, TNF-α, partially fun... | BeFree,CTD_human,LHGDN | 25503960 | Detail |
0.246 | Neoplasm Metastasis | Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in v... | BeFree,CTD_human,LHGDN | 25504108 | Detail |
0.246 | Neoplasm Metastasis | These results indicated that miR-518c-5p regulates the growth and metastasis of ... | BeFree,CTD_human,LHGDN | 25536052 | Detail |
0.246 | Neoplasm Metastasis | Finally, IL-24 when combined with CXCR4 inhibitors (AMD3100, SJA5) or with CXCR4... | BeFree,CTD_human,LHGDN | 25775124 | Detail |
0.246 | Neoplasm Metastasis | Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knock... | BeFree,CTD_human,LHGDN | 25866254 | Detail |
0.246 | Neoplasm Metastasis | High expression of CXCR4 may help oral squamous cancer cells invade local tissue... | BeFree,CTD_human,LHGDN | 25866764 | Detail |
0.246 | Neoplasm Metastasis | Recent evidence suggests that CXCR4-mediated proliferation and metastasis of tum... | BeFree,CTD_human,LHGDN | 25884570 | Detail |
0.246 | Neoplasm Metastasis | Downregulation of the CXCR4/CXCL12 axis thus reduces cancer growth and metastasi... | BeFree,CTD_human,LHGDN | 25960214 | Detail |
0.246 | Neoplasm Metastasis | Here, we show that CD133(+)/CXCR4(+) cancer-initiating cells (CIC) directly isol... | BeFree,CTD_human,LHGDN | 26141860 | Detail |
0.246 | Neoplasm Metastasis | The chemokine receptor CXCR4 is active in melanoma metastasis, although the mech... | BeFree,CTD_human,LHGDN | 26205821 | Detail |
0.246 | Neoplasm Metastasis | Chemokine receptor CXCR4 is involved in tumor growth, angiogenesis and metastasi... | BeFree,CTD_human,LHGDN | 26321665 | Detail |
<0.001 | multiple endocrine neoplasia | NA | BeFree | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
0.120 | Neuralgia | NA | CTD_human | Detail | |
0.008 | neuroblastoma | The present study indicates that the inflammatory cytokine, TNF-α, partially fun... | BeFree,GAD,LHGDN | 25503960 | Detail |
0.008 | neuroblastoma | Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and ind... | BeFree,GAD,LHGDN | 25774696 | Detail |
0.008 | neuroblastoma | Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively... | BeFree,GAD,LHGDN | 25955316 | Detail |
<0.001 | neutropenia | NA | BeFree | Detail | |
<0.001 | obesity | NA | BeFree | Detail | |
<0.001 | Opportunistic Infections | NA | BeFree | Detail | |
<0.001 | Degenerative polyarthritis | Although chemokine stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 ... | BeFree | 24516346 | Detail |
0.011 | osteosarcoma | Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in... | BeFree,LHGDN | 24618817 | Detail |
0.011 | osteosarcoma | Our study provides further evidence of the contributions of hypoxia and the HIF-... | BeFree,LHGDN | 25444927 | Detail |
0.011 | osteosarcoma | Higher CXCR4 mRNA levels were detected in the osteosarcoma cell lines compared t... | BeFree,LHGDN | 25890096 | Detail |
0.006 | ovarian carcinoma | Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA i... | BeFree | 25149650 | Detail |
0.012 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Periodontal Diseases | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
0.001 | Pituitary Diseases | NA | BeFree | Detail | |
0.003 | Pituitary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | pneumonia | This two-layered microfluidic system provides a feasible platform for perfusion ... | BeFree | 25486073 | Detail |
<0.001 | polyps | NA | BeFree | Detail | |
<0.001 | prolactinoma | NA | BeFree | Detail | |
0.031 | Prostatic Neoplasms | Here we show that, in the LNCaP prostate-tumor cell line, androgens coordinate t... | BeFree,LHGDN | 25884570 | Detail |
<0.001 | pterygium | NA | BeFree | Detail | |
<0.001 | pulmonary fibrosis | NA | BeFree | Detail | |
0.009 | rhabdomyosarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | sarcoidosis | NA | BeFree | Detail | |
0.006 | systemic scleroderma | NA | BeFree,LHGDN | Detail | |
<0.001 | Septicemia | NA | BeFree | Detail | |
0.009 | Stomach Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
<0.001 | Superinfection | HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors ... | BeFree | 26178998 | Detail |
<0.001 | synovial sarcoma | Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localize... | BeFree | 25613038 | Detail |
<0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
0.009 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
<0.001 | tuberculosis | NA | BeFree | Detail | |
0.003 | Tuberculosis, Pulmonary | NA | BeFree,LHGDN | Detail | |
<0.001 | uveitis | NA | BeFree | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
0.002 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.001 | diffuse large B-cell lymphoma | CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decrea... | BeFree | 25231113 | Detail |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, T-Cell, Cutaneous | Importantly, our results demonstrate that BZ inhibits expression of the chemokin... | BeFree | 25681335 | Detail |
0.002 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
0.003 | Liver failure | NA | LHGDN | Detail | |
<0.001 | Synovial Cyst | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Hamman-Rich syndrome | NA | BeFree | Detail | |
<0.001 | Hypogammaglobulinemia | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
0.001 | Small cell carcinoma of lung | Thus, CXCR4 may prove to be a promising target for the prevention and effective ... | BeFree | 25504108 | Detail |
<0.001 | Genital ulceration | NA | BeFree | Detail | |
<0.001 | Thyroid Gland Follicular Adenoma | NA | BeFree | Detail | |
<0.001 | Cutaneous Melanoma | Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with ... | BeFree | 25211166 | Detail |
0.001 | esophageal carcinoma | Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for t... | BeFree | 26130416 | Detail |
<0.001 | congenital heart disease | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of mouth | These results indicated that miR-518c-5p regulates the growth and metastasis of ... | BeFree | 25536052 | Detail |
0.002 | Malignant neoplasm of mouth | The CXCL12-CXCR4 biological axis consisting of the chemotactic factor CXCL12 and... | BeFree | 25866764 | Detail |
0.003 | Secondary malignant neoplasm of lung | This study reveals the highly plastic and dynamic nature of CXCR4 expression in ... | BeFree | 24651452 | Detail |
0.003 | Secondary malignant neoplasm of lung | The mechanism of pulmonary metastasis inhibition involved decreased expression o... | BeFree | 25402182 | Detail |
0.003 | Secondary malignant neoplasm of lung | Importantly, we show that knockdown of either CXCR4 or MIF abrogates MSC homing ... | BeFree | 25712213 | Detail |
0.003 | Secondary malignant neoplasm of lung | Additionally, IL-24, when combined with CXCR4 inhibitors exhibited enhanced anti... | BeFree | 25775124 | Detail |
<0.001 | Secondary malignant neoplasm of kidney | In in vivo experiments, the knockout of CXCR4 suppressed the development of meta... | BeFree | 25504108 | Detail |
0.003 | Secondary malignant neoplasm of bone | We compared the expression levels of C-X-C chemokine receptor type 4 (CXCR4) in ... | BeFree | 25504108 | Detail |
0.003 | Secondary malignant neoplasm of bone | In addition, we used a xenograft mouse model established by intracardiac injecti... | BeFree | 25773070 | Detail |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | Chronic obstructive asthma (with obstructive pulmonary disease) | CXCL12/CXCR4 and CCL19/CCR7 enhanced fibrocyte transmigration in the Asthma AE g... | BeFree | 25441632 | Detail |
<0.001 | Malnutrition | NA | BeFree | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
<0.001 | Aortic Aneurysm, Abdominal | NA | BeFree | Detail | |
0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
0.008 | Tumor Progression | The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell... | BeFree | 24992171 | Detail |
0.008 | Tumor Progression | In the network of chemokine signaling pathways, recent reports have described th... | BeFree | 25114911 | Detail |
0.008 | Tumor Progression | Stromal cell-derived factor 1 (SDF-1) and its receptor, CXCR4, play an important... | BeFree | 25150783 | Detail |
0.008 | Tumor Progression | The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperativ... | BeFree | 25232565 | Detail |
0.003 | Rhabdomyosarcoma, Embryonal | NA | LHGDN | Detail | |
<0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
0.003 | cholangiocarcinoma | NA | BeFree,LHGDN | Detail | |
0.004 | hemangioblastoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of salivary gland | NA | BeFree | Detail | |
0.002 | Lip and oral cavity carcinoma | These results indicated that miR-518c-5p regulates the growth and metastasis of ... | BeFree | 25536052 | Detail |
0.002 | Lip and oral cavity carcinoma | The CXCL12-CXCR4 biological axis consisting of the chemotactic factor CXCL12 and... | BeFree | 25866764 | Detail |
<0.001 | Metastatic malignant neoplasm to brain | NA | BeFree | Detail | |
<0.001 | Hyperviscosity syndrome | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of female breast | NA | BeFree | Detail | |
<0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
0.007 | pancreatic carcinoma | Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by dere... | BeFree | 24840182 | Detail |
0.007 | pancreatic carcinoma | Furthermore, we show that Nodal promotes pancreatic cancer cell migration and in... | BeFree | 25557170 | Detail |
0.007 | pancreatic carcinoma | Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural i... | BeFree | 25605248 | Detail |
<0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
<0.001 | desquamative interstitial pneumonia | NA | BeFree | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
0.003 | Papillary thyroid carcinoma | The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell... | BeFree | 24992171 | Detail |
0.003 | Papillary thyroid carcinoma | A previous study demonstrated CXCR4 and nucleolin co-expressed in cell lines, an... | BeFree | 25326811 | Detail |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
<0.001 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of lung | Endogenous CXCR4 protein expression levels varied among the four human lung canc... | BeFree | 25775124 | Detail |
0.003 | Disease Progression | NA | LHGDN | Detail | |
<0.001 | Sepsis | NA | BeFree | Detail | |
<0.001 | Psoriasiform eczema | NA | BeFree | Detail | |
<0.001 | Epithelial hyperplasia of skin | NA | BeFree | Detail | |
<0.001 | Chronic heart failure | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) analy... | BeFree | 25303939 | Detail |
<0.001 | Acquired aplastic anemia | NA | BeFree | Detail | |
0.002 | Myelokathexis | NA | BeFree | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
0.001 | Carcinoma breast stage IV | Liposomes were modified with anti-CXCR4 antibodies to target metastatic breast c... | BeFree | 24467226 | Detail |
<0.001 | Malignant neoplasm of stomach stage IV | NA | BeFree | Detail | |
<0.001 | inflammatory breast carcinoma | NA | BeFree | Detail | |
<0.001 | Stage IV Ovarian Carcinoma | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their cl... | BeFree | 25400739 | Detail |
<0.001 | Metastatic melanoma | Studies ascertaining the potential utility of CXCR4 mRNA as a prognosticator in ... | BeFree | 25211166 | Detail |
<0.001 | Non-small cell lung cancer metastatic | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the hypopharynx | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | intraocular lymphoma | NA | BeFree | Detail | |
<0.001 | Vascular Neoplasms | NA | BeFree | Detail | |
<0.001 | Bone Marrow Neoplasms | NA | BeFree | Detail | |
0.002 | cervix carcinoma | ATO inhibited CXCR4-mediated cervical cancer cell invasion in vitro and distant ... | BeFree | 25047463 | Detail |
0.002 | cervix carcinoma | Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. | BeFree | 25114911 | Detail |
<0.001 | Healing ulcer | NA | BeFree | Detail | |
<0.001 | Tumor necrosis | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma - lymphoplasmacytic | MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases wit... | BeFree | 25819228 | Detail |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Congenital neutropenia | NA | BeFree | Detail | |
<0.001 | intrahepatic cholangiocarcinoma | In conclusion, our result shows that high CXCR4 expression is associated with IH... | BeFree | 25471741 | Detail |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Growth Hormone-Secreting Pituitary Adenoma | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | NA | BeFree | Detail | |
<0.001 | intestinal cancer | NA | BeFree | Detail | |
0.008 | Malignant neoplasm of pancreas | Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by dere... | BeFree | 24840182 | Detail |
0.008 | Malignant neoplasm of pancreas | Furthermore, we show that Nodal promotes pancreatic cancer cell migration and in... | BeFree | 25557170 | Detail |
0.008 | Malignant neoplasm of pancreas | Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural i... | BeFree | 25605248 | Detail |
<0.001 | Secondary malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.008 | Malignant neoplasm of prostate | Autocrine CXCL8-stimulation (i) increased expression of CXCR1 and CXCR2 in PTEN-... | BeFree | 24970800 | Detail |
0.008 | Malignant neoplasm of prostate | Moreover, the prognostic effects of Tpl2 and expressional correlation between Tp... | BeFree | 25274482 | Detail |
<0.001 | Hematologic Neoplasms | Bruton's tyrosine kinase (BTK) and the chemokine receptor CXCR4 are linked in va... | BeFree | 25083818 | Detail |
<0.001 | Primary immune deficiency disorder | NA | BeFree | Detail | |
0.450 | WHIM syndrome | We propose that FLNA interaction with ICL3 is central for endocytosis and signal... | BeFree,CLINVAR,CTD_human,MGD,ORPHANET | 25355818 | Detail |
0.450 | WHIM syndrome | In competitive mouse bone marrow (BM) transplantation experiments, Cxcr4 haploin... | BeFree,CLINVAR,CTD_human,MGD,ORPHANET | 25662009 | Detail |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
0.004 | Secondary malignant neoplasm of liver | The expression of six genes was significantly different in primary tumors compar... | BeFree | 25301403 | Detail |
0.004 | Secondary malignant neoplasm of liver | CXCR2, CXCR4, and their chemokine ligands were evaluated in liver metastases of ... | BeFree | 25580640 | Detail |
<0.001 | dementia | NA | BeFree | Detail | |
<0.001 | Overweight | NA | BeFree | Detail | |
<0.001 | Recurrent tumor | The upregulation of CXCR4 by VEGFR inhibitors was dependent on TGFβ/TGFβR, but n... | BeFree | 25676691 | Detail |
<0.001 | Malignant neoplasm of esophagus | Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for t... | BeFree | 26130416 | Detail |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
0.001 | Ewings sarcoma | Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. | BeFree | 24651452 | Detail |
0.001 | Ewings sarcoma | For validation at protein and functional level, the identified isoforms and norm... | BeFree | 26321665 | Detail |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of mouth | NA | BeFree | Detail | |
0.003 | Osteosarcoma of bone | Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in... | BeFree | 24618817 | Detail |
0.003 | Osteosarcoma of bone | Our study provides further evidence of the contributions of hypoxia and the HIF-... | BeFree | 25444927 | Detail |
0.003 | Osteosarcoma of bone | Higher CXCR4 mRNA levels were detected in the osteosarcoma cell lines compared t... | BeFree | 25890096 | Detail |
<0.001 | Aqueous Humor Disorders | NA | BeFree | Detail | |
0.004 | Carcinogenesis | Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine re... | BeFree | 24929539 | Detail |
0.004 | Carcinogenesis | The animal experiment was confirmed that silencing of CXCR4 gene by siRNA can ob... | BeFree | 25149650 | Detail |
0.004 | Carcinogenesis | SNCG, MAP2, SDF-1 and CXCR4 may play an important role in the carcinogenesis, pr... | BeFree | 25400739 | Detail |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
0.008 | prostate carcinoma | Autocrine CXCL8-stimulation (i) increased expression of CXCR1 and CXCR2 in PTEN-... | BeFree | 24970800 | Detail |
0.008 | prostate carcinoma | Moreover, the prognostic effects of Tpl2 and expressional correlation between Tp... | BeFree | 25274482 | Detail |
0.002 | Epithelial ovarian cancer | NA | BeFree | Detail | |
<0.001 | invasive cancer | NA | BeFree | Detail | |
<0.001 | Refractory cancer | CXCR4(WHIM) somatic mutations are common Waldenstrom's Macroglobulinemia (WM), a... | BeFree | 24912431 | Detail |
<0.001 | Sentinel node (disorder) | NA | BeFree | Detail | |
0.026 | breast carcinoma | This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing-... | BeFree | 24467226 | Detail |
0.026 | breast carcinoma | Inhibition of breast cancer metastasis with microRNA-302a by downregulation of C... | BeFree | 25030358 | Detail |
0.026 | breast carcinoma | Targeting the CXCL12-CXCR4/JAK2/STAT3 signaling pathway may be a potential thera... | BeFree | 25310198 | Detail |
0.026 | breast carcinoma | In a panel of LTED cell lines, C-X-C chemokine receptor type 7 (CXCR7) and CXCR4... | BeFree | 25358600 | Detail |
0.026 | breast carcinoma | ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to re... | BeFree | 25376609 | Detail |
0.026 | breast carcinoma | Previously, we and others demonstrated that CXCR4 surface expression is an indep... | BeFree | 25544759 | Detail |
0.026 | breast carcinoma | Finally, we found that ANGPTL2 and CXCR4 expression levels within primary tumor ... | BeFree | 25773070 | Detail |
0.026 | breast carcinoma | Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatost... | BeFree | 26251419 | Detail |
0.010 | Primary myelofibrosis | Abnormal expression of HMGA2 and CXCR4 in IM granulocytes was dependent on the p... | BeFree | 16990584 | Detail |
0.002 | Carcinoma of lung | Endogenous CXCR4 protein expression levels varied among the four human lung canc... | BeFree | 25775124 | Detail |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.008 | Secondary malignant neoplasm of lymph node | We reduced the cell surface level of CXCR4 and called the technique intracellula... | BeFree | 25866764 | Detail |
0.004 | colon carcinoma | The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperativ... | BeFree | 25232565 | Detail |
0.004 | colon carcinoma | Platelet activation with a PAR1 agonist triggered TGF-β secretion, which induced... | BeFree | 25846512 | Detail |
0.004 | colon carcinoma | Targeted therapy utilizing the CXCR4/CXCL12 axis could be an effective strategy ... | BeFree | 25960214 | Detail |
0.004 | stomach carcinoma | Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine re... | BeFree | 24929539 | Detail |
0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | airway disease | NA | BeFree | Detail | |
0.003 | Central neuroblastoma | The present study indicates that the inflammatory cytokine, TNF-α, partially fun... | BeFree | 25503960 | Detail |
0.003 | Central neuroblastoma | Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and ind... | BeFree | 25774696 | Detail |
0.003 | Central neuroblastoma | Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively... | BeFree | 25955316 | Detail |
0.002 | Malignant neoplasm of kidney | CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. | BeFree | 24991762 | Detail |
<0.001 | Chronic neutropenia | NA | BeFree | Detail | |
<0.001 | Idiopathic Inflammatory Myopathies | NA | BeFree | Detail | |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | thrombocytosis | NA | BeFree | Detail | |
<0.001 | Immunodeficiency congenital | Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a... | BeFree | 25355818 | Detail |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
<0.001 | Infectious disease of lung | NA | BeFree | Detail | |
<0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
<0.001 | Renal cancer metastatic | NA | BeFree | Detail | |
<0.001 | cancer recurrence | NA | BeFree | Detail | |
<0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
0.005 | Malignant neoplasm of ovary | Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA i... | BeFree | 25149650 | Detail |
0.002 | HIV disease progression | NA | GAD | Detail | |
<0.001 | endometrial adenocarcinoma | NA | BeFree | Detail | |
0.002 | Squamous cell carcinoma of the head and neck | CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head a... | BeFree | 25474514 | Detail |
0.002 | Squamous cell carcinoma of the head and neck | Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell... | BeFree | 25866764 | Detail |
<0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
<0.001 | Mammary Carcinoma, Human | NA | BeFree | Detail | |
<0.001 | Myxoid cyst | NA | BeFree | Detail | |
<0.001 | Morphologically altered structure | NA | BeFree | Detail | |
0.004 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | These findings demonstrate, for the first time, that CD9 plays a key role in the... | BeFree | 26320102 | Detail |
<0.001 | Chronic myeloproliferative disorder | NA | BeFree | Detail | |
<0.001 | Pancreatic intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma | NA | BeFree | Detail | |
<0.001 | Atypical Ductal Breast Hyperplasia | NA | BeFree | Detail | |
<0.001 | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
<0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | Neuroblastic Tumor | In NB, CXCR4 expression was shown to be associated to highly aggressive undiffer... | BeFree | 25955316 | Detail |
<0.001 | Conventional Chondrosarcoma | NA | BeFree | Detail | |
<0.001 | Mucoepidermoid carcinoma of salivary gland | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | differentiated thyroid gland carcinoma | Well-differentiated thyroid cancer with a minor poorly differentiated component:... | BeFree | 24992171 | Detail |
0.002 | renal carcinoma | CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. | BeFree | 24991762 | Detail |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
0.041 | Mammary Neoplasms | Thus, understanding how CXCR4 expression is regulated in breast cancer cells cou... | BeFree,LHGDN | 25773070 | Detail |
<0.001 | Hereditary Melanoma | NA | BeFree | Detail | |
<0.001 | Neuropathogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Expansion | NA | BeFree | Detail | |
0.002 | Xenograft Model | Herein we demonstrate that the chemokine receptor CXCR4 is essential to the LIC ... | BeFree | 26058076 | Detail |
0.010 | colorectal cancer | SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colore... | BeFree,GAD | 25150783 | Detail |
0.010 | colorectal cancer | Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knock... | BeFree,GAD | 25866254 | Detail |
<0.001 | Pneumocystis jiroveci pneumonia | NA | BeFree | Detail | |
0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Endometrioid | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
<0.001 | tumor vasculature | TAMs were the predominant cells expressing immunoreactive CXCR4 in chemotherapy-... | BeFree | 26269531 | Detail |
<0.001 | Secondary Focal Segmental Glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Painful Bladder Syndrome | NA | BeFree | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
0.001 | Idiopathic Pulmonary Fibrosis | The clinical relevance of these data was confirmed by strong CXCR4 expression in... | BeFree | 25103869 | Detail |
<0.001 | Recurrent infections (sinusitis and bacterial pneumonia and meningitis) | NA | BeFree | Detail | |
<0.001 | severe congenital neutropenia | NA | BeFree | Detail | |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Loss of CXCR4 targeted key T-ALL regulators, including the MYC pathway, and decr... | BeFree | 26058075 | Detail |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphobl... | BeFree | 26058076 | Detail |
0.007 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,LHGDN | Detail | |
0.009 | liver carcinoma | Together, these data suggest that CD90+CXCR4+ HCC cells may be CTSCs and selecti... | BeFree,GAD,LHGDN | 25672610 | Detail |
<0.001 | Allergic rhinitis (disorder) | NA | BeFree | Detail | |
<0.001 | Combined immunodeficiency disease | NA | BeFree | Detail | |
0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Clear-cell metastatic renal cell carcinoma | NA | BeFree | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Micropapillary carcinoma | NA | BeFree | Detail | |
0.120 | Juvenile arthritis | NA | CTD_human | Detail | |
0.001 | Triple Negative Breast Neoplasms | During co-culture CXCR4 protein expression of TNBC cell lines HCC1806 and HCC193... | BeFree | 25420519 | Detail |
0.001 | Triple Negative Breast Neoplasms | Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. | BeFree | 25544759 | Detail |
0.014 | Infection | NA | LHGDN | Detail | |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
0.003 | acquired immunodeficiency syndrome | NA | BeFree,LHGDN | Detail | |
0.006 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
0.010 | Primary myelofibrosis | This trafficking pattern could not be attributed to discordant expression of int... | BeFree,LHGDN | 25461253 | Detail |
0.003 | AIDS Dementia Complex | NA | BeFree,LHGDN | Detail | |
<0.001 | Alzheimer's disease | NA | BeFree | Detail | |
<0.001 | aplastic anemia | CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltratio... | BeFree | 25647836 | Detail |
<0.001 | Angina, Unstable | NA | BeFree | Detail | |
0.003 | Anoxia | NA | LHGDN | Detail | |
<0.001 | arteriosclerosis | CXCR4 blockade induces atherosclerosis by affecting neutrophil function. | BeFree | 24816217 | Detail |
0.004 | arthritis | NA | BeFree,LHGDN | Detail | |
0.125 | rheumatoid arthritis | Although chemokine stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 ... | BeFree,CTD_human,LHGDN | 24516346 | Detail |
0.005 | asthma | The CXCR4/CXCL12 axis contributes to chemotaxis of fibrocytes in patients in the... | BeFree,GAD | 25441632 | Detail |
0.002 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | atherosclerosis | CXCR4 blockade induces atherosclerosis by affecting neutrophil function. | BeFree | 24816217 | Detail |
<0.001 | Autoimmune Diseases | The chemokine CXCL12 and its G protein-coupled receptors CXCR4 and ACKR3 are imp... | BeFree | 26216880 | Detail |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
<0.001 | bipolar disorder | Treatment of the CXCR4(+) NPCs with a pharmacological inhibitor of glycogen synt... | BeFree | 25733313 | Detail |
0.002 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
0.003 | Bladder Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
<0.001 | Bone Diseases | NA | BeFree | Detail | |
<0.001 | Bone neoplasms | NA | BeFree | Detail | |
<0.001 | Brain Diseases | NA | BeFree | Detail | |
0.005 | Brain Neoplasms | The role of CXCL12 and CXCR4 in the development of brain tumors requires further... | BeFree,LHGDN | 24934367 | Detail |
0.005 | Brain Neoplasms | Differential expression of CXCR4 and CXCR7 in brain tumors derived cells compare... | BeFree,LHGDN | 25227814 | Detail |
0.029 | Malignant neoplasm of breast | This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing-... | BeFree,GAD | 24467226 | Detail |
0.029 | Malignant neoplasm of breast | Inhibition of breast cancer metastasis with microRNA-302a by downregulation of C... | BeFree,GAD | 25030358 | Detail |
0.029 | Malignant neoplasm of breast | Targeting the CXCL12-CXCR4/JAK2/STAT3 signaling pathway may be a potential thera... | BeFree,GAD | 25310198 | Detail |
0.029 | Malignant neoplasm of breast | In a panel of LTED cell lines, C-X-C chemokine receptor type 7 (CXCR7) and CXCR4... | BeFree,GAD | 25358600 | Detail |
0.029 | Malignant neoplasm of breast | ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to re... | BeFree,GAD | 25376609 | Detail |
0.029 | Malignant neoplasm of breast | Previously, we and others demonstrated that CXCR4 surface expression is an indep... | BeFree,GAD | 25544759 | Detail |
0.029 | Malignant neoplasm of breast | Finally, we found that ANGPTL2 and CXCR4 expression levels within primary tumor ... | BeFree,GAD | 25773070 | Detail |
0.029 | Malignant neoplasm of breast | Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatost... | BeFree,GAD | 26251419 | Detail |
<0.001 | Breast Diseases | NA | BeFree | Detail | |
<0.001 | bronchiolitis obliterans | NA | BeFree | Detail | |
0.004 | Malignant tumor of colon | The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperativ... | BeFree | 25232565 | Detail |
0.004 | Malignant tumor of colon | Platelet activation with a PAR1 agonist triggered TGF-β secretion, which induced... | BeFree | 25846512 | Detail |
0.004 | Malignant tumor of colon | Targeted therapy utilizing the CXCR4/CXCL12 axis could be an effective strategy ... | BeFree | 25960214 | Detail |
<0.001 | female breast carcinoma | NA | BeFree | Detail | |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
0.003 | Noninfiltrating Intraductal Carcinoma | NA | BeFree,LHGDN | Detail | |
0.003 | Non-small cell lung carcinoma | Here, we show that CD133(+)/CXCR4(+) cancer-initiating cells (CIC) directly isol... | BeFree | 26141860 | Detail |
0.003 | renal cell carcinoma | HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in r... | BeFree | 26439684 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ATO inhibited CXCR4-mediated cervical cancer cell invasion in vitro and distant metastasis in vivo. | DisGeNET | Detail |
Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal ... | DisGeNET | Detail |
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activ... | DisGeNET | Detail |
Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knockdown-induced invasio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngioma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These observations demonstrate a potentially reno-protective role for CXCR4 in diabetes that is impe... | DisGeNET | Detail |
These observations demonstrate a potentially reno-protective role for CXCR4 in diabetes that is impe... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although CXCR4 expression was also increased in biopsy tissue from patients with diabetic nephropath... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for treatment of EC patie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-depe... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in patients failing antir... | DisGeNET | Detail |
The CX3CR1 A allele and lower genetic scores may restrict the switch of HIV-1 tropism from R5 to X4. | DisGeNET | Detail |
CXCR4 usage can emerge independently, in multiple lineages, along the course of HIV infection.The mo... | DisGeNET | Detail |
When pDC were depleted prior to HIV-1 infection, the induction of IFN-I and interferon-stimulated ge... | DisGeNET | Detail |
Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as entry coreceptor is spe... | DisGeNET | Detail |
Our study demonstrates that individuals may be infected by minority X4 viruses from a population tha... | DisGeNET | Detail |
The interaction of HIV-1 and target cells involves sequential binding of the viral gp120 Env protein... | DisGeNET | Detail |
Chemokine receptors CXCR4 and CCR5 are indispensable co-receptors for HIV-1 entry into host cells. | DisGeNET | Detail |
HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors CCR5 and CXCR4 from ... | DisGeNET | Detail |
Treatment failure with drug-resistant virus is particularly interesting because it tends to be rare,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
There is marked evidence that the SDF-1/CXCR4 axis is involved in the pathogenesis of leukemia and t... | DisGeNET | Detail |
CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia. | DisGeNET | Detail |
It has previously been shown that SDF1/CXCR4-induced migration is dependent on activation of downstr... | DisGeNET | Detail |
Circulating chronic lymphocytic leukemia (CLL) cells display an abnormal increase in the surface lev... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. | DisGeNET | Detail |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression. | DisGeNET | Detail |
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. | DisGeNET | Detail |
A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in ... | DisGeNET | Detail |
Patients with defective NK cells showed a profound gene expression decrease in AML blasts for cytoki... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunophenotypic analysis of lung tumor cells intravenously injected or spontaneously disseminated t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine receptor 4 (CXCR4) is ... | DisGeNET | Detail |
These results demonstrate crosstalk among WIP1, CXCR4 and GRK5, which may be important for the aggre... | DisGeNET | Detail |
Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma. | DisGeNET | Detail |
Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopat... | DisGeNET | Detail |
Deregulation of the CXCR4/CXCL12 axis was reported in melanoma tumorigenesis while also linked to BR... | DisGeNET | Detail |
PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In 176 paired clinical samples, BTK and CXCR4 expression was lower in myeloma cells purified from a ... | DisGeNET | Detail |
It has previously been shown that SDF1/CXCR4-induced migration is dependent on activation of downstr... | DisGeNET | Detail |
Several chemokines/chemokine receptors such as CXCL12, CCL3, CXCR4 and CCR1 attract multiple myeloma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This trafficking pattern could not be attributed to discordant expression of integrins or chemokine ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, a significant association was revealed between positive CXCR4 expression and age (less ... | DisGeNET | Detail |
Because breast cancer patient survival inversely correlates with metastasis, we engineered vehicles ... | DisGeNET | Detail |
Furthermore, coexpression of HIF-1α and CXCR4 was significantly higher in patients with distant meta... | DisGeNET | Detail |
This study reveals the highly plastic and dynamic nature of CXCR4 expression in Ewing sarcoma and su... | DisGeNET | Detail |
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the express... | DisGeNET | Detail |
Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine receptor 4 (CXCR4) is ... | DisGeNET | Detail |
The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell adhesion) and BRAF ... | DisGeNET | Detail |
More promisingly, miR-302a inhibited the invasion and metastasis of breast cancer cells in vitro and... | DisGeNET | Detail |
Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in ... | DisGeNET | Detail |
These findings demonstrate the first evidence that epigenetic silencing of CXCR4 makes the cells ine... | DisGeNET | Detail |
CXCR7 was not detectable in secondary tumors but CXCR4 was expressed. | DisGeNET | Detail |
CXCR4 is a marker of poor prognosis in various neoplasms, correlating with metastatic disease and de... | DisGeNET | Detail |
The subsequent increase in circulating granulocyte number, with an increase in serum CXCL12 and gran... | DisGeNET | Detail |
The chemokine receptor CXCR4 and signal transducer and activator of transcription 3 (STAT3) play an ... | DisGeNET | Detail |
Our findings suggest that ΔNP63α regulation of CXCR4 may have strong implications in the regulation ... | DisGeNET | Detail |
SNCG, MAP2, SDF-1 and CXCR4 may play an important role in the carcinogenesis, progression, invasion ... | DisGeNET | Detail |
The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. | DisGeNET | Detail |
In conclusion, our result shows that high CXCR4 expression is associated with IHCC progression and m... | DisGeNET | Detail |
The present study indicates that the inflammatory cytokine, TNF-α, partially functions through the N... | DisGeNET | Detail |
Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metas... | DisGeNET | Detail |
These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a dow... | DisGeNET | Detail |
Finally, IL-24 when combined with CXCR4 inhibitors (AMD3100, SJA5) or with CXCR4 siRNA demonstrated ... | DisGeNET | Detail |
Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knockdown-induced invasio... | DisGeNET | Detail |
High expression of CXCR4 may help oral squamous cancer cells invade local tissues and metastasize to... | DisGeNET | Detail |
Recent evidence suggests that CXCR4-mediated proliferation and metastasis of tumor cells is regulate... | DisGeNET | Detail |
Downregulation of the CXCR4/CXCL12 axis thus reduces cancer growth and metastasis. | DisGeNET | Detail |
Here, we show that CD133(+)/CXCR4(+) cancer-initiating cells (CIC) directly isolated from patient-de... | DisGeNET | Detail |
The chemokine receptor CXCR4 is active in melanoma metastasis, although the mechanism for the promot... | DisGeNET | Detail |
Chemokine receptor CXCR4 is involved in tumor growth, angiogenesis and metastasis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The present study indicates that the inflammatory cytokine, TNF-α, partially functions through the N... | DisGeNET | Detail |
Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in ... | DisGeNET | Detail |
Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively increased NB dissem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although chemokine stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 induce degradation o... | DisGeNET | Detail |
Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma. | DisGeNET | Detail |
Our study provides further evidence of the contributions of hypoxia and the HIF-1α/CXCR4 pathway to ... | DisGeNET | Detail |
Higher CXCR4 mRNA levels were detected in the osteosarcoma cell lines compared to BMSCs. | DisGeNET | Detail |
Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This two-layered microfluidic system provides a feasible platform for perfusion culture, and was use... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we show that, in the LNCaP prostate-tumor cell line, androgens coordinate the expression of CXC... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors CCR5 and CXCR4 from ... | DisGeNET | Detail |
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Importantly, our results demonstrate that BZ inhibits expression of the chemokine receptor CXCR4 in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, CXCR4 may prove to be a promising target for the prevention and effective treatment of metasta... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopat... | DisGeNET | Detail |
Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for treatment of EC patie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a dow... | DisGeNET | Detail |
The CXCL12-CXCR4 biological axis consisting of the chemotactic factor CXCL12 and its specific recept... | DisGeNET | Detail |
This study reveals the highly plastic and dynamic nature of CXCR4 expression in Ewing sarcoma and su... | DisGeNET | Detail |
The mechanism of pulmonary metastasis inhibition involved decreased expression of CXC chemokine rece... | DisGeNET | Detail |
Importantly, we show that knockdown of either CXCR4 or MIF abrogates MSC homing to tumors in an in v... | DisGeNET | Detail |
Additionally, IL-24, when combined with CXCR4 inhibitors exhibited enhanced anti-metastatic activity... | DisGeNET | Detail |
In in vivo experiments, the knockout of CXCR4 suppressed the development of metastastic lesions in t... | DisGeNET | Detail |
We compared the expression levels of C-X-C chemokine receptor type 4 (CXCR4) in the human small cell... | DisGeNET | Detail |
In addition, we used a xenograft mouse model established by intracardiac injection of tumor cells to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCL12/CXCR4 and CCL19/CCR7 enhanced fibrocyte transmigration in the Asthma AE group and in patients... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell adhesion) and BRAF ... | DisGeNET | Detail |
In the network of chemokine signaling pathways, recent reports have described the SDF-1α/CXCR4 axis ... | DisGeNET | Detail |
Stromal cell-derived factor 1 (SDF-1) and its receptor, CXCR4, play an important role in angiogenesi... | DisGeNET | Detail |
The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a dow... | DisGeNET | Detail |
The CXCL12-CXCR4 biological axis consisting of the chemotactic factor CXCL12 and its specific recept... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the express... | DisGeNET | Detail |
Furthermore, we show that Nodal promotes pancreatic cancer cell migration and invasion, induces epit... | DisGeNET | Detail |
Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of both CXCR4 (a chemokine inducing cytoskeletal rearrangement and cell adhesion) and BRAF ... | DisGeNET | Detail |
A previous study demonstrated CXCR4 and nucleolin co-expressed in cell lines, and the present study ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endogenous CXCR4 protein expression levels varied among the four human lung cancer cell lines. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis revealed decreas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Liposomes were modified with anti-CXCR4 antibodies to target metastatic breast cancer (MBC) cells an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance. | DisGeNET | Detail |
Studies ascertaining the potential utility of CXCR4 mRNA as a prognosticator in melanoma have focuse... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ATO inhibited CXCR4-mediated cervical cancer cell invasion in vitro and distant metastasis in vivo. | DisGeNET | Detail |
Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, our result shows that high CXCR4 expression is associated with IHCC progression and m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the express... | DisGeNET | Detail |
Furthermore, we show that Nodal promotes pancreatic cancer cell migration and invasion, induces epit... | DisGeNET | Detail |
Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Autocrine CXCL8-stimulation (i) increased expression of CXCR1 and CXCR2 in PTEN-deficient CaP cells ... | DisGeNET | Detail |
Moreover, the prognostic effects of Tpl2 and expressional correlation between Tpl2 and EMT-related m... | DisGeNET | Detail |
Bruton's tyrosine kinase (BTK) and the chemokine receptor CXCR4 are linked in various hematologic ma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We propose that FLNA interaction with ICL3 is central for endocytosis and signaling of WT and WHIM-l... | DisGeNET | Detail |
In competitive mouse bone marrow (BM) transplantation experiments, Cxcr4 haploinsufficiency was suff... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of six genes was significantly different in primary tumors compared with their matche... | DisGeNET | Detail |
CXCR2, CXCR4, and their chemokine ligands were evaluated in liver metastases of colorectal cancer in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The upregulation of CXCR4 by VEGFR inhibitors was dependent on TGFβ/TGFβR, but not HGF/MET, signalin... | DisGeNET | Detail |
Moreover, therapy targeting the CXCL12/CXCR4 axis may open a new direction for treatment of EC patie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. | DisGeNET | Detail |
For validation at protein and functional level, the identified isoforms and normal CXCR4 were cloned... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma. | DisGeNET | Detail |
Our study provides further evidence of the contributions of hypoxia and the HIF-1α/CXCR4 pathway to ... | DisGeNET | Detail |
Higher CXCR4 mRNA levels were detected in the osteosarcoma cell lines compared to BMSCs. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine receptor 4 (CXCR4) is ... | DisGeNET | Detail |
The animal experiment was confirmed that silencing of CXCR4 gene by siRNA can obviously inhibit the ... | DisGeNET | Detail |
SNCG, MAP2, SDF-1 and CXCR4 may play an important role in the carcinogenesis, progression, invasion ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Autocrine CXCL8-stimulation (i) increased expression of CXCR1 and CXCR2 in PTEN-deficient CaP cells ... | DisGeNET | Detail |
Moreover, the prognostic effects of Tpl2 and expressional correlation between Tpl2 and EMT-related m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4(WHIM) somatic mutations are common Waldenstrom's Macroglobulinemia (WM), and are associated wi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing--significantly reduc... | DisGeNET | Detail |
Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression. | DisGeNET | Detail |
Targeting the CXCL12-CXCR4/JAK2/STAT3 signaling pathway may be a potential therapeutic strategy for ... | DisGeNET | Detail |
In a panel of LTED cell lines, C-X-C chemokine receptor type 7 (CXCR7) and CXCR4 were upregulated co... | DisGeNET | Detail |
ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer... | DisGeNET | Detail |
Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic fa... | DisGeNET | Detail |
Finally, we found that ANGPTL2 and CXCR4 expression levels within primary tumor tissues from breast ... | DisGeNET | Detail |
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or ... | DisGeNET | Detail |
Abnormal expression of HMGA2 and CXCR4 in IM granulocytes was dependent on the presence and the muta... | DisGeNET | Detail |
Endogenous CXCR4 protein expression levels varied among the four human lung cancer cell lines. | DisGeNET | Detail |
NA | DisGeNET | Detail |
We reduced the cell surface level of CXCR4 and called the technique intracellular sequestration. By ... | DisGeNET | Detail |
The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression... | DisGeNET | Detail |
Platelet activation with a PAR1 agonist triggered TGF-β secretion, which induced EMT of SW620 human ... | DisGeNET | Detail |
Targeted therapy utilizing the CXCR4/CXCL12 axis could be an effective strategy for treatment of col... | DisGeNET | Detail |
Stromal cell-derived factor-1 (SDF-1) (CXC chemokine ligand-12)/CXC chemokine receptor 4 (CXCR4) is ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The present study indicates that the inflammatory cytokine, TNF-α, partially functions through the N... | DisGeNET | Detail |
Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in ... | DisGeNET | Detail |
Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively increased NB dissem... | DisGeNET | Detail |
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare congenital imm... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cel... | DisGeNET | Detail |
Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These findings demonstrate, for the first time, that CD9 plays a key role in the CXCR4-mediated migr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In NB, CXCR4 expression was shown to be associated to highly aggressive undifferentiated tumors, whi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneit... | DisGeNET | Detail |
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, understanding how CXCR4 expression is regulated in breast cancer cells could suggest approache... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Herein we demonstrate that the chemokine receptor CXCR4 is essential to the LIC activity of T-ALL le... | DisGeNET | Detail |
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activ... | DisGeNET | Detail |
Treatment of CRC cells with the CXCR4 antagonist AMD3100 attenuated SEMA3F knockdown-induced invasio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
TAMs were the predominant cells expressing immunoreactive CXCR4 in chemotherapy-treated mouse tumors... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The clinical relevance of these data was confirmed by strong CXCR4 expression in vessels close to fi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Loss of CXCR4 targeted key T-ALL regulators, including the MYC pathway, and decreased leukemia initi... | DisGeNET | Detail |
CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Together, these data suggest that CD90+CXCR4+ HCC cells may be CTSCs and selective elimination of th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
During co-culture CXCR4 protein expression of TNBC cell lines HCC1806 and HCC1937 was significantly ... | DisGeNET | Detail |
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This trafficking pattern could not be attributed to discordant expression of integrins or chemokine ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4 blockade induces atherosclerosis by affecting neutrophil function. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although chemokine stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 induce degradation o... | DisGeNET | Detail |
The CXCR4/CXCL12 axis contributes to chemotaxis of fibrocytes in patients in the Asthma AE group, wh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CXCR4 blockade induces atherosclerosis by affecting neutrophil function. | DisGeNET | Detail |
The chemokine CXCL12 and its G protein-coupled receptors CXCR4 and ACKR3 are implicated in cancer an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Treatment of the CXCR4(+) NPCs with a pharmacological inhibitor of glycogen synthase kinase 3, a kno... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of CXCL12 and CXCR4 in the development of brain tumors requires further research. | DisGeNET | Detail |
Differential expression of CXCR4 and CXCR7 in brain tumors derived cells compared to non-tumoral sam... | DisGeNET | Detail |
This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing--significantly reduc... | DisGeNET | Detail |
Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression. | DisGeNET | Detail |
Targeting the CXCL12-CXCR4/JAK2/STAT3 signaling pathway may be a potential therapeutic strategy for ... | DisGeNET | Detail |
In a panel of LTED cell lines, C-X-C chemokine receptor type 7 (CXCR7) and CXCR4 were upregulated co... | DisGeNET | Detail |
ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer... | DisGeNET | Detail |
Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic fa... | DisGeNET | Detail |
Finally, we found that ANGPTL2 and CXCR4 expression levels within primary tumor tissues from breast ... | DisGeNET | Detail |
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression... | DisGeNET | Detail |
Platelet activation with a PAR1 agonist triggered TGF-β secretion, which induced EMT of SW620 human ... | DisGeNET | Detail |
Targeted therapy utilizing the CXCR4/CXCL12 axis could be an effective strategy for treatment of col... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we show that CD133(+)/CXCR4(+) cancer-initiating cells (CIC) directly isolated from patient-de... | DisGeNET | Detail |
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma. | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr2:136,114,349-136,119,177
- Variant Type
- snv
Genome browser